Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)

Cesare Gridelli, Solange Peters, Tony Mok, Marina Chiara Garassino, Luis Paz‐Ares, Ilaria Attili, Filippo de Marinis